Article
Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC
16 Oct 2019
Abstract excerpt
INTRODUCTION: SCLC accounts for approximately 250,000 deaths worldwide each year. Acquisition of adequate tumor biopsy samples is challenging, and liquid biopsies present an alternative option for patient stratification and response monitoring. METHODS: We applied whole genome next-generation sequencing to circulating free DNA (cfDNA) from 39 patients with limited-stage (LS) SCLC and 30 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
